Concepedia

Dattatrya Shetti

DS

Statistics

Publications

6

Citations

396

H-Index

6

Active since

2019

Affiliations

South China University of Technology(Current)

Dattatrya Shetti is an author at South China University of Technology specializing in pharmacology, oncology, and medicine.

ORCID

Publications per year

2019–2020

6

Publications

6

RGD functionalized chitosan nanoparticle mediated targeted delivery of raloxifene selectively suppresses angiogenesis and tumor growth in breast cancer

Amit Singh Yadav, N. N. V. Radharani, Mahadeo Gorain et al. · Nanoscale · 2020 · 100 citations

, , +17

miR-29b-3p promotes progression of MDA-MB-231 triple-negative breast cancer cells through downregulating TRAF3

Bao Zhang, Dattatrya Shetti, Conghui Fan et al. · Biological Research · 2019 · 91 citations · Full text

, , +16

Low Dose of Paclitaxel Combined with XAV939 Attenuates Metastasis, Angiogenesis and Growth in Breast Cancer by Suppressing Wnt Signaling

Dattatrya Shetti, Bao Zhang, Conghui Fan et al. · Cells · 2019 · 88 citations · Full text

, , +16

Erianin Inhibits Proliferation and Induces Apoptosis of HaCaT Cells via ROS-Mediated JNK/c-Jun and AKT/mTOR Signaling Pathways

Canlong Mo, Dattatrya Shetti, Kun Wei · Molecules · 2019 · 54 citations · Full text

, , +17

Resveratrol loaded oxidized mesoporous carbon nanoparticles: A promising tool to treat triple negative breast cancer

Conghui Fan, Fanhui Kong, Dattatrya Shetti et al. · Biochemical and Biophysical Research Communications · 2019 · 34 citations

, , +16

1–5 of 6